1. Home
  2. BYND vs CNTB Comparison

BYND vs CNTB Comparison

Compare BYND & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$7.22

Market Cap

117.8M

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

BUY

Current Price

$0.77

Market Cap

140.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BYND
CNTB
Founded
2009
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.8M
140.4M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
BYND
CNTB
Price
$7.22
$0.77
Analyst Decision
Sell
Strong Buy
Analyst Count
3
8
Target Price
★ $12.50
$5.88
AVG Volume (30 Days)
1.1M
★ 1.5M
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.69
N/A
EPS
★ N/A
N/A
Revenue
★ $275,496,000.00
$64,000.00
Revenue This Year
N/A
$11,291.47
Revenue Next Year
N/A
$74.30
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.40
$0.79
52 Week High
$15.47
$3.82

Technical Indicators

Market Signals
Indicator
BYND
CNTB
Relative Strength Index (RSI) 37.81 34.08
Support Level $0.63 N/A
Resistance Level $12.52 $2.84
Average True Range (ATR) 0.41 0.07
MACD -0.05 0.02
Stochastic Oscillator 25.91 4.63

Price Performance

Historical Comparison
BYND
CNTB

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: